Daily Archive: October 12, 2020

Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited Announce an Exclusive Licensing Agreement to Develop and Commercialize Tenalisib, a Dual PI3K Delta and Gamma Inhibitor for Oncology in Greater China

La Chaux-de-Fonds, Switzerland and Shanghai, China. October 12, 2020, Oct. 12, 2020 (GLOBE NEWSWIRE) — Rhizen Pharmaceuticals S. A. (Rhizen), a Switzerland-based privately held clinical-stage biopharmaceutical company, and Curon Biopharmaceutical Limited (Curon), a clinical-stage innovative biopharmaceutical company with facility in Shanghai announced today that they have entered into an exclusive licensing agreement for the development […]

S. Korea set to implement mandatory mask use

SEOUL, Poeple will be required to wear face masks on mass transportation and in public places starting Tuesday to help better combat the coronavirus outbreak. The requirement is in line...

S. Korea, U.S. analyzing N. Korea’s new ICBM: defense ministry

SEOUL, Military authorities are analyzing details of North Korea’s newest intercontinental ballistic missile (ICBM) unveiled in a massive parade over the weekend, including how many warheads it can carry, officials...